News
SBFMW
0.0350
0.00%
0.0000
Weekly Report: what happened at SBFM last week (0803-0807)?
Weekly Report · 2d ago
Sunshine Biopharma launches generic amoxicillin formulation in Canada
TipRanks · 5d ago
Sunshine announces approval of generic Dienogest tablets for Canadian market
TipRanks · 08/04 13:16
EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval
Benzinga · 08/04 12:31
Sunshine Biopharma Adjusts Series B Warrant Terms
TipRanks · 08/03 13:19
Weekly Report: what happened at SBFM last week (0727-0731)?
Weekly Report · 08/03 09:08
Sunshine Biopharma announces approval of generic Ondansetron tablets
TipRanks · 07/28 12:21
Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting
Barchart · 07/28 07:00
Weekly Report: what happened at SBFM last week (0720-0724)?
Weekly Report · 07/27 09:09
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 07/20 21:05
Sunshine Biopharma Announces ATM Equity Sales Agreement
TipRanks · 07/20 20:48
Sunshine Biopharma Inks $4M At-The-Market Sales Agreement With Aegis Capital
Benzinga · 07/20 20:30
Sunshine Biopharma announces publication of new results on MR1-114
TipRanks · 07/20 12:45
Weekly Report: what happened at SBFM last week (0713-0717)?
Weekly Report · 07/20 09:08
Weekly Report: what happened at SBFM last week (0706-0710)?
Weekly Report · 07/13 09:08
Sunshine Biopharma Settles Dispute With Former Nora President
TipRanks · 07/10 21:19
Weekly Report: what happened at SBFM last week (0629-0703)?
Weekly Report · 07/06 09:09
Weekly Report: what happened at SBFM last week (0622-0626)?
Weekly Report · 06/29 09:08
Sunshine Biopharma receives Canadian approval for generic Arimidex
TipRanks · 06/25 12:20
Sunshine Biopharma Announces Approval Of Generic Anastrozole Tablets Of 1mg For Canadian Market
Benzinga · 06/25 12:03
More
Webull provides a variety of real-time SBFMW stock news. You can receive the latest news about Sunshine Biopharma Inc through multiple platforms. This information may help you make smarter investment decisions.
About SBFMW
Sunshine Biopharma, Inc. is a Canada-based pharmaceutical company. The Company offers and researches life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has over 32 additional generic prescription drugs. In addition, the Company is conducting a proprietary drug development program which consists of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for treatment of SARS Coronavirus infections. The Company operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). It also operates two wholly owned subsidiaries: NoraPharma Inc., which has a portfolio of pharmaceutical products consisting of approximately 61 generic prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells non-prescription over-the-counter (OTC) products.